1. Jianfei Zheng, Xudong Xiang, Bing Xiao,et al. Xuebijing combined with ulinastation benefits patients with sepsis: A meta-analysis. Am J Emerg Med. 2018 Mar;36(3):480-487. https://doi.org/10.1016/j.ajem.2017.12.007(PMID: 29373169)
2. Gao J, Kong L, Liu S, Feng Z, Shen H, Liu Q. A prospective multicenter clinical study of Xuebijing injection in the treatment of sepsis and multiple organ dysfunction syndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2015;27(6):465–70. https://doi: 10.3760/cma.j.issn.2095-4352.2015.06.010(PMID: 26049185)
3. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992; 101 :1644–55. https:// doi: 10.1378/chest.101.6.1644 .(PMID: 1303622)
4. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003; 31:1250–1256. https:// doi: 10.1097/01.CCM.0000050454.01978.3B.(PMID: 12682500).